Recombinant human ACE2: acing out angiotensin II in ARDS therapy
- PMID: 29237475
- PMCID: PMC5729230
- DOI: 10.1186/s13054-017-1882-z
Recombinant human ACE2: acing out angiotensin II in ARDS therapy
Keywords: Clinical trial; Lung injury; Renin-angiotensin system.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Wosten-van Asperen RM, Lutter R, Specht PA, Moll GN, van Woensel JB, van der Loos CM, van Goor H, Kamilic J, Florquin S, Bos AP. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol. 2011;225(4):618–27. doi: 10.1002/path.2987. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous